40 research outputs found

    Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Titanium dioxide (TiO<sub>2</sub>) nanomaterials have considerable beneficial uses as photocatalysts and solar cells. It has been established for many years that pigment-grade TiO<sub>2 </sub>(200 nm sphere) is relatively inert when internalized into a biological model system (in vivo or in vitro). For this reason, TiO<sub>2 </sub>nanomaterials are considered an attractive alternative in applications where biological exposures will occur. Unfortunately, metal oxides on the nanoscale (one dimension < 100 nm) may or may not exhibit the same toxic potential as the original material. A further complicating issue is the effect of modifying or engineering of the nanomaterial to be structurally and geometrically different from the original material.</p> <p>Results</p> <p>TiO<sub>2 </sub>nanospheres, short (< 5 ÎŒm) and long (> 15 ÎŒm) nanobelts were synthesized, characterized and tested for biological activity using primary murine alveolar macrophages and in vivo in mice. This study demonstrates that alteration of anatase TiO<sub>2 </sub>nanomaterial into a fibre structure of greater than 15 ÎŒm creates a highly toxic particle and initiates an inflammatory response by alveolar macrophages. These fibre-shaped nanomaterials induced inflammasome activation and release of inflammatory cytokines through a cathepsin B-mediated mechanism. Consequently, long TiO<sub>2 </sub>nanobelts interact with lung macrophages in a manner very similar to asbestos or silica.</p> <p>Conclusions</p> <p>These observations suggest that any modification of a nanomaterial, resulting in a wire, fibre, belt or tube, be tested for pathogenic potential. As this study demonstrates, toxicity and pathogenic potential change dramatically as the shape of the material is altered into one that a phagocytic cell has difficulty processing, resulting in lysosomal disruption.</p

    Association of Accelerometry-Measured Physical Activity and Cardiovascular Events in Mobility-Limited Older Adults: The LIFE (Lifestyle Interventions and Independence for Elders) Study.

    Get PDF
    BACKGROUND:Data are sparse regarding the value of physical activity (PA) surveillance among older adults-particularly among those with mobility limitations. The objective of this study was to examine longitudinal associations between objectively measured daily PA and the incidence of cardiovascular events among older adults in the LIFE (Lifestyle Interventions and Independence for Elders) study. METHODS AND RESULTS:Cardiovascular events were adjudicated based on medical records review, and cardiovascular risk factors were controlled for in the analysis. Home-based activity data were collected by hip-worn accelerometers at baseline and at 6, 12, and 24&nbsp;months postrandomization to either a physical activity or health education intervention. LIFE study participants (n=1590; age 78.9±5.2 [SD] years; 67.2% women) at baseline had an 11% lower incidence of experiencing a subsequent cardiovascular event per 500&nbsp;steps taken per day based on activity data (hazard ratio, 0.89; 95% confidence interval, 0.84-0.96; P=0.001). At baseline, every 30&nbsp;minutes spent performing activities ≄500&nbsp;counts per minute (hazard ratio, 0.75; confidence interval, 0.65-0.89 [P=0.001]) were also associated with a lower incidence of cardiovascular events. Throughout follow-up (6, 12, and 24&nbsp;months), both the number of steps per day (per 500&nbsp;steps; hazard ratio, 0.90, confidence interval, 0.85-0.96 [P=0.001]) and duration of activity ≄500&nbsp;counts per minute (per 30&nbsp;minutes; hazard ratio, 0.76; confidence interval, 0.63-0.90 [P=0.002]) were significantly associated with lower cardiovascular event rates. CONCLUSIONS:Objective measurements of physical activity via accelerometry were associated with cardiovascular events among older adults with limited mobility (summary score &gt;10 on the Short Physical Performance Battery) both using baseline and longitudinal data. CLINICAL TRIAL REGISTRATION:URL: http://www.clinicaltrials.gov. Unique identifier: NCT01072500

    A comparison of dispersing media for various engineered carbon nanoparticles

    No full text
    Abstract Background With the increased manufacture and use of carbon nanoparticles (CNP) there has been increasing concern about the potential toxicity of fugitive CNP in the workplace and ambient environment. To address this matter a number of investigators have conducted in vitro and in vivo toxicity assessments. However, a variety of different approaches for suspension of these particles (culture media, Tween 80, dimethyl sulfoxide, phosphate-buffered saline, fetal calf serum, and others), and different sources of materials have generated potentially conflicting outcomes. The quality of the dispersion of nanoparticles is very dependent on the medium used to suspend them, and this then will most likely affect the biological outcomes. Results In this work, the distributions of different CNP (sources and types) have been characterized in various media. Furthermore, the outcome of instilling the different agglomerates, or size distributions, was examined in mouse lungs after one and seven days. Our results demonstrated that CNP suspended in serum produced particle suspensions with the fewest large agglomerates, and the most uniform distribution in mouse lungs. In addition, no apparent clearance of instilled CNP took place from lungs even after seven days. Conclusion This work demonstrates that CNP agglomerates are present in all dispersing vehicles to some degree. The vehicle that contains some protein, lipid or protein/lipid component disperses the CNP best, producing fewer large CNP agglomerates. In contrast, vehicles absent of lipid and protein produce the largest CNP agglomerates. The source of the CNP is also a factor in the degree of particle agglomeration within the same vehicle.</p

    A comparison of dispersing media for various engineered carbon nanoparticles-9

    No full text
    <p><b>Copyright information:</b></p><p>Taken from "A comparison of dispersing media for various engineered carbon nanoparticles"</p><p>http://www.particleandfibretoxicology.com/content/4/1/6</p><p>Particle and Fibre Toxicology 2007;4():6-6.</p><p>Published online 27 Jul 2007</p><p>PMCID:PMC1950524.</p><p></p> SWNT from CNI, ) MWNT from SES Research, and ) MWNT from NanoLab. All particle suspensions were at 5 mg/ml. Magnification – 400×

    A comparison of dispersing media for various engineered carbon nanoparticles-10

    No full text
    <p><b>Copyright information:</b></p><p>Taken from "A comparison of dispersing media for various engineered carbon nanoparticles"</p><p>http://www.particleandfibretoxicology.com/content/4/1/6</p><p>Particle and Fibre Toxicology 2007;4():6-6.</p><p>Published online 27 Jul 2007</p><p>PMCID:PMC1950524.</p><p></p>SWNT from CNI, ) MWNT from SES Research, and ) MWNT from NanoLab. All particle suspensions were at 5 mg/ml. Magnification – 400×

    A comparison of dispersing media for various engineered carbon nanoparticles-5

    No full text
    <p><b>Copyright information:</b></p><p>Taken from "A comparison of dispersing media for various engineered carbon nanoparticles"</p><p>http://www.particleandfibretoxicology.com/content/4/1/6</p><p>Particle and Fibre Toxicology 2007;4():6-6.</p><p>Published online 27 Jul 2007</p><p>PMCID:PMC1950524.</p><p></p> SWNT from CNI, ) MWNT from SES Research, and ) MWNT from NanoLab. All particle suspensions were at 5 mg/ml. Magnification – 400×

    A comparison of dispersing media for various engineered carbon nanoparticles-15

    No full text
    <p><b>Copyright information:</b></p><p>Taken from "A comparison of dispersing media for various engineered carbon nanoparticles"</p><p>http://www.particleandfibretoxicology.com/content/4/1/6</p><p>Particle and Fibre Toxicology 2007;4():6-6.</p><p>Published online 27 Jul 2007</p><p>PMCID:PMC1950524.</p><p></p>SWNT from CNI, ) MWNT from SES Research, and ) MWNT from NanoLab. All particle suspensions were at 5 mg/ml. Magnification – 400×
    corecore